Experienced in ABO Incompatibility

Mikko P. Pakarinen

Pl 347, 
Helsinki, FI 
Experienced in ABO Incompatibility
Pl 347, 
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Mikko Pakarinen practices in Helsinki, Finland. Pakarinen is rated as an Experienced expert by MediFind in the treatment of ABO Incompatibility. Their top areas of expertise are Short Bowel Syndrome, Biliary Atresia, Total Intestinal Aganglionosis, Small Bowel Resection, and Liver Transplant.

Their clinical research consists of co-authoring 275 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of ABO Incompatibility.

Locations

Pl 347, Helsinki, 00029, Finland
Other Locations
Pl 281, Helsinki, 00029, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Drug, Device, Other
Study Phase: Phase 3
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Randomized, Open-label, 24-Week Safety, Efficacy, and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A Randomized, Open-label, 24-Week Safety, Efficacy, and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Device, Other, Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

275 Total Publications

Decrease of post-portoenterostomy liver fibrosis in a nationally centralized cohort of biliary atresia patients.
Decrease of post-portoenterostomy liver fibrosis in a nationally centralized cohort of biliary atresia patients.
Journal: Journal of pediatric surgery
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pakarinen's expertise for a condition
ConditionClose
View All 25 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile